Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| Bladder cancer | R-HSA-9700206 | map05219 | amylocaine | 4891 | drug-path |
| Asthma | R-HSA-444620 | map05310 | amylocaine | 4891 | drug-path |
| Parkinson's disease | R-HSA-1643685 | 0 | amylocaine | 4891 | drug-path |
| GnRH signaling pathway | R-HSA-168638 | map04912 | amylocaine | 4891 | drug-path |
| Allograft rejection | R-HSA-9679028 | map05330 | amylocaine | 4891 | drug-path |
| Vascular smooth muscle contraction | R-HSA-445355 | map04270 | amylocaine | 4891 | drug-path |
| Type I diabetes mellitus | R-HSA-5683209 | map04940 | amylocaine | 4891 | drug-path |
| Natural killer cell mediated cytotoxicity | R-HSA-5218921 | map04650 | pheniramine | 4761 | drug-path |
| Autoimmune thyroid disease | R-HSA-1643685 | map05320 | pheniramine | 4761 | drug-path |
| Huntington's disease | R-HSA-1643685 | 0 | pheniramine | 4761 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | pheniramine | 4761 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | pheniramine | 4761 | drug-path |
| Allograft rejection | R-HSA-9679028 | map05330 | pheniramine | 4761 | drug-path |
| Phosphatidylinositol signaling system | R-HSA-1280215 | map04070 | pheniramine | 4761 | drug-path |
| p53 signaling pathway | R-HSA-168638 | map04115 | pheniramine | 4761 | drug-path |
| Graft-versus-host disease | R-HSA-1643685 | map05332 | cyclic adenosine monophosphate | 2165 | drug-path |
| Hematopoietic cell lineage | R-HSA-173752 | map04640 | cyclic adenosine monophosphate | 2165 | drug-path |
| Autoimmune thyroid disease | R-HSA-1643685 | map05320 | cyclic adenosine monophosphate | 2165 | drug-path |
| Antigen processing and presentation | R-HSA-1236975 | map04612 | cyclic adenosine monophosphate | 2165 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | cyclic adenosine monophosphate | 2165 | drug-path |